Insider Transactions in Q3 2024 at Mind Medicine (Mind Med) Inc. (MNMD)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,771
-3.5%
|
$98,855
$5.98 P/Share
|
|
Sep 25
2024
|
Carrie Liao Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,352
-2.31%
|
$11,760
$5.98 P/Share
|
|
Sep 25
2024
|
Mark Sullivan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,430
-2.43%
|
$22,150
$5.98 P/Share
|
|
Sep 25
2024
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,871
-1.95%
|
$34,355
$5.98 P/Share
|
|
Aug 23
2024
|
David W Gryska |
BUY
Open market or private purchase
|
Direct |
3,500
+16.79%
|
$17,500
$5.98 P/Share
|
|
Aug 21
2024
|
Miri Halperin Wernli Executive President |
SELL
Payment of exercise price or tax liability
|
Direct |
32,595
-13.87%
|
$195,570
$6.17 P/Share
|
|
Aug 21
2024
|
Miri Halperin Wernli Executive President |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.54%
|
$150,000
$3.7 P/Share
|
|
Aug 20
2024
|
Robert Barrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.09%
|
$3,000
$6.12 P/Share
|
|
Aug 19
2024
|
Robert Barrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.09%
|
$3,000
$6.31 P/Share
|